Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 5 recruiting now full pipeline small index

Agitation: full-pipeline trial registry

5 of 9 indexed Agitation trials are currently recruiting.

Corpus placement: #1,916 of 28,707 conditions by registered trial count.

9 US clinical trials · 5 currently recruiting · #1,916 of 28,707 conditions by registered trial count

Agitation: 9 US clinical trials tracked, 5 recruiting.

Agitation is the subject of 9 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. 4 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is St. Luke's-Roosevelt Hospital Center, running 1 of these trials.

Enrollment posture brief

Registry condition agitation

OPEN 5 | RECR 56% | LATE 4 | EARLY 3 | RANK #1916 | SPON 1

Nearest open-share peer: Advanced Colorectal Cancer (56% recruiting · 9 trials)

Agitation (this)56%Acute Lymphoblastic Leukemia55.6%Acute Respiratory Distress S55.6%Acute Otitis Media22.2%Acute Heart Failure11.1%
Open-enrollment share among volume-matched conditions near Agitation

Agitation lists 5 open slots (56% of 9 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Agitation on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Agitation is recruiting above its size-band peers.

    5 of 9 indexed trials (55.6%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Agitation trials is spread across many organizations.

    St. Luke's-Roosevelt Hospital Center accounts for 1 of 9 trials (11.1%). 9 distinct sponsors appear on at least one study for this condition label.

  3. Typical Agitation enrolment sits around 120 participants.

    Median target enrolment is 120 among the 9 trials that report a genuine target (sentinel values excluded). 2 of those (22.2%) plan for fewer than 100 participants.

  4. Agitation research is mostly interventional.

    8 interventional and 1 observational studies make up this index (88.9% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 23Phase 33Phase 41

Phase Distribution

PhaseTrial count
Phase 2 3
Phase 3 3
Phase 4 1

Named interventions

Most-linked intervention names on Agitation records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Drug
3 trials
interview Other
1 trials
T2:C100 Drug
1 trials
Placebo - 2 Placebo DMTS Patches Drug
1 trials
6 cm2 - 1 Active and 1 Placebo DMTS Patches Drug
1 trials
12 cm2 - 2 Active DMTS Patches Drug
1 trials
KarX-EC Drug
1 trials
risperidone Drug
1 trials

US sites by state

Facility locations filed on Agitation trials. A trial with sites in several states counts in each.

New York 4 trials
Florida 4 trials
California 4 trials
South Carolina 2 trials
Ohio 2 trials
New Jersey 2 trials
Connecticut 2 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Agitation page

9 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Agitation condition card totals 9 registered trials; most-linked intervention Placebo; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.